{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:07:23Z","timestamp":1785416843656,"version":"3.56.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,29]]},"DOI":"10.7759\/cureus.53160","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T16:21:40Z","timestamp":1706545300000},"source":"Crossref","is-referenced-by-count":2,"title":["Bullous Pemphigoid Associated With the Use of Sacubitril\/Valsartan: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Daniel A","family":"Martin Arsanios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M","family":"G\u00f3mez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mu\u00f1oz-Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Montealegre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Quintero Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Calder\u00f3n-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/TME.0000000000000372","article-title":"Bullous pemphigoid: a multifactorial review of a dermatologic mystery","volume":"43","author":"Martinez N","year":"2021","unstructured":"Martinez N, Gadler T, Benson A, Lalicata K, Truman L. Bullous pemphigoid: a multifactorial review of a dermatologic mystery. Adv Emerg Nurs J. 2021, 43:272-8. 10.1097\/TME.0000000000000372","journal-title":"Adv Emerg Nurs J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2089331","article-title":"Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review","volume":"33","author":"Husein-ElAhmed H","year":"2022","unstructured":"Husein-ElAhmed H, Steinhoff M. Bullous pemphigoid induced by biologic drugs in psoriasis: a systematic review. J Dermatolog Treat. 2022, 33:2886-93. 10.1080\/09546634.2022.2089331","journal-title":"J Dermatolog Treat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20199007","article-title":"Bullous pemphigoid","volume":"94","author":"Miyamoto D","year":"2019","unstructured":"Miyamoto D, Santi CG, Aoki V, Maruta CW. Bullous pemphigoid. An Bras Dermatol. 2019, 94:133-46. 10.1590\/abd1806-4841.20199007","journal-title":"An Bras Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3457","article-title":"A systematic review of drug-induced pemphigoid","volume":"100","author":"Verheyden MJ","year":"2020","unstructured":"Verheyden MJ, Bilgic A, Murrell DF. A systematic review of drug-induced pemphigoid. Acta Derm Venereol. 2020, 100:adv00224. 10.2340\/00015555-3457","journal-title":"Acta Derm Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-023-01397-w","article-title":"Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid","volume":"41","author":"Liu M","year":"2023","unstructured":"Liu M, Yuan M, Sun W, Li Z, Zhou X, Wang C. Clinical characterization, treatment, and outcome of nivolumab-induced bullous pemphigoid. Invest New Drugs. 2023, 41:802-7. 10.1007\/s10637-023-01397-w","journal-title":"Invest New Drugs"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.1587","article-title":"Association between medication use and bullous pemphigoid: a systematic review and meta-analysis","volume":"156","author":"Liu SD","year":"2020","unstructured":"Liu SD, Chen WT, Chi CC. Association between medication use and bullous pemphigoid: a systematic review and meta-analysis. JAMA Dermatol. 2020, 156:891-900. 10.1001\/jamadermatol.2020.1587","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.754499","article-title":"Sacubitril-valsartan, clinical benefits and related mechanisms of action in heart failure with reduced ejection fraction. A review","volume":"8","author":"Pascual-Figal D","year":"2021","unstructured":"Pascual-Figal D, Bay\u00e9s-Genis A, Beltr\u00e1n-Troncoso P, et al.. Sacubitril-valsartan, clinical benefits and related mechanisms of action in heart failure with reduced ejection fraction. A review. Front Cardiovasc Med. 2021, 8:754499. 10.3389\/fcvm.2021.754499","journal-title":"Front Cardiovasc Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.06.020","article-title":"Sacubitril\/valsartan: neprilysin inhibition 5 years after PARADIGM-HF","volume":"8","author":"Docherty KF","year":"2020","unstructured":"Docherty KF, Vaduganathan M, Solomon SD, McMurray JJ. Sacubitril\/valsartan: neprilysin inhibition 5 years after PARADIGM-HF. JACC Heart Fail. 2020, 8:800-10. 10.1016\/j.jchf.2020.06.020","journal-title":"JACC Heart Fail"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X17666210831142452","article-title":"Sacubitril\/valsartan: a new dawn has begun! A revisited review","volume":"18","author":"Abdelnabi M","year":"2022","unstructured":"Abdelnabi M, Saleh Y, Almaghraby A, Girgis H, Gerges F. Sacubitril\/valsartan: a new dawn has begun! A revisited review. Curr Cardiol Rev. 2022, 18:e310821195982. 10.2174\/1573403X17666210831142452","journal-title":"Curr Cardiol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/220029-bullous-pemphigoid-associated-with-the-use-of-sacubitrilvalsartan-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:15:32Z","timestamp":1707509732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/220029-bullous-pemphigoid-associated-with-the-use-of-sacubitrilvalsartan-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.53160","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}